Pharmaceutical Industry

Sen. Charles Schumer, D-N.Y., center, accompanied by, from left, Sen. Jeanne Shaheen, D-N.H., Sen. Patty Murray, D-Wash., Sen. Joe Manchin, D-W.Va., Sen. Edward Markey, D-Mass., speak during a news conference on opioid and heroin abuse on Feb. 11 on Capitol Hill. (AP photo)

Magazine

Manchin: Addiction should be bigger focus of FDA approval

February 29, 2016 5:01 am

Business

Sanders seizes on report that Pfizer will dodge $35 billion in taxes

Joseph Lawler -

February 25, 2016 7:21 pm

The Senate voted 80-6 to advance the nomination of Dr. Robert Califf to a final vote, which will be held after 30 hours of debate. Califf needs a simple majority to be confirmed. (AP Photo)

Healthcare

Senate tees up final vote for FDA nominee

Robert King -

February 22, 2016 11:46 pm

Sens. Joe Manchin, center, and Ed Markey, right, are concerned about Dr. Robert Califf's ties to the drug industry. (Graeme Jennings/Washington Examiner)

Healthcare

Dem senators start ‘uphill fight’ against FDA nominee

Robert King -

February 22, 2016 7:40 pm

The number of federal lobbyists dropped 25 percent, but the number of state lobbyists grew 10 percent. (AP Photo/Haraz N. Ghanbari)

Healthcare

Report: Lobbyists flocking from D.C. to state capitals

Anna Giaritelli -

February 12, 2016 12:53 am

Rep. Orrin Hatch, R-Utah, is worried President Obama will issue an executive order to give Medicare the power to negotiate lower drug prices. (AP Photo/J. Scott Applewhite)

Healthcare

Hatch slams possible Obama move on drug prices

Robert King -

February 11, 2016 5:16 pm

Here are three recent problems and three possible solutions to the problem of money in politics. (AP Photo)

Op-Eds

Three solutions for money in politics

Gary Shapiro -

February 9, 2016 5:01 am

Healthcare

Super bowl drug ads made some sick

Robert King -

February 8, 2016 10:50 pm

Former drug company CEO Martin Shkreli said Rep. Trey Gowdy tried to

Healthcare

Shkreli: Gowdy ‘conniving’ at hearing

Robert King -

February 5, 2016 12:20 am

House Oversight and Reform Committee ranking member Rep. Elijah Cummings, D-Md., left, questions former Turing Pharmaceutical executive Martin Shkreli, who declined to answer questions because of a federal indictment on unrelated securities fraud charges. (AP Photo/Susan Walsh)

Healthcare

Lavish lifestyles for drug execs unleash torrent of criticism

Robert King -

February 4, 2016 7:34 pm

1...127128129...157 Page 128 of 157

Tag: Pharmaceutical Industry

Manchin: Addiction should be bigger focus of FDA approval

Sanders seizes on report that Pfizer will dodge $35 billion in taxes

Senate tees up final vote for FDA nominee

Dem senators start ‘uphill fight’ against FDA nominee

Report: Lobbyists flocking from D.C. to state capitals

Hatch slams possible Obama move on drug prices

Three solutions for money in politics

Super bowl drug ads made some sick

Shkreli: Gowdy ‘conniving’ at hearing

Lavish lifestyles for drug execs unleash torrent of criticism

NEWS

POLICY

COMMENTARY

RESTORING AMERICA